Next Generation Cryopreservation To Help Advance Cell And Gene Therapies

By Michael Osborne SVP, Commercialization, X-Therma

In the field of cryopreservation, DMSO is often used in 5 to 10% formulation along with HSA/FBS as a cryoprotectant agent for cells and tissues. In cell preservation specifically, cell functionality is greatly impaired by Dimethyl sulfoxide (DMSO), as a multitude of studies show a low rate of cell survival after being thawed from the cryopreservation process. This challenge is often incredibly costly for scientific development and manufacturing organizations — not only financially, but its significant role in disrupting the ability to complete the work.

Find out how X-therma's introduction of XT-Thrive as a next-generation cryoprotectant agent is helping to carve a new path to accelerate optimal treatments for patients in the overall field of biologics.